These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21571347)

  • 1. [Validation of the Spanish version of the Subjective Well-being under Neuroleptic Scale (SWN-K) in patients with schizophrenia].
    Sanjúan J; Haro JM; Mauriño J; Díez T; Ballesteros J
    Med Clin (Barc); 2012 Feb; 138(4):151-4. PubMed ID: 21571347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the Italian version of the subjective well-being under neuroleptic (SWN) scale in schizophrenic outpatients.
    Balestrieri M; Giaroli G; Mazzi M; Bellantuono C
    Pharmacopsychiatry; 2006 May; 39(3):81-4. PubMed ID: 16721695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric evaluation of the Subjective Well-being Under Neuroleptic Treatment Scale (SWN) in patients with schizophrenia, their relatives and controls.
    Vothknecht S; Meijer C; Zwinderman A; Kikkert M; Dekker J; van Beveren N; Schoevers R; de Haan L;
    Psychiatry Res; 2013 Mar; 206(1):62-7. PubMed ID: 23021423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric properties of the Subjective Well-Being Under Neuroleptics scale and the Subjective Deficit Syndrome Scale.
    de Haan L; Weisfelt M; Dingemans PM; Linszen DH; Wouters L
    Psychopharmacology (Berl); 2002 Jun; 162(1):24-8. PubMed ID: 12107613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales.
    Wolters HA; Knegtering H; van den Bosch RJ; Wiersma D
    Schizophr Res; 2009 Jul; 112(1-3):114-8. PubMed ID: 19395241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intercultural differences in factor structure of the SWN-20 in patients with schizophrenia.
    Hwang SS; Kim EY; Kim SH; Kim YS; Ahn YM
    Compr Psychiatry; 2013 Oct; 54(7):970-3. PubMed ID: 23763873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of paliperidone extended release on subjective well-being and responses in patients with schizophrenia.
    Kim SW; Yoon JS; Kim YS; Ahn YM; Kim CE; Go HJ; Chee IS; Jung SW; Chung YC; Kim YD; Joe S; Lee J; Kwon YJ; Yoon BH; Jae YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):228-35. PubMed ID: 22516251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translation and cross-cultural adaption of an instrument measuring patient's well-being under treatment for schizophrenia.
    Julaeha J; Athiyah U; Maramis MM; Sugianto A; Hermansyah A
    J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):341-347. PubMed ID: 34214321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective well-being in schizophrenia as measured with the Subjective Well-Being under Neuroleptic Treatment scale: a review.
    Vothknecht S; Schoevers RA; de Haan L
    Aust N Z J Psychiatry; 2011 Mar; 45(3):182-92. PubMed ID: 21438745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of subjective well-being in schizophrenic patients with gait parameters, expert-rated motor disturbances, and psychopathological status.
    Putzhammer A; Perfahl M; Pfeiff L; Hajak G
    Pharmacopsychiatry; 2005 May; 38(3):132-8. PubMed ID: 15902585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medication.
    Widschwendter CG; Kemmler G; Rettenbacher MA; Yalcin-Siedentopf N; Hofer A
    BMC Psychiatry; 2018 Jun; 18(1):212. PubMed ID: 29954366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
    Wehmeier PM; Kluge M; Schneider E; Schacht A; Wagner T; Schreiber W
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):703-12. PubMed ID: 17289237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia.
    Wehmeier PM; Kluge M; Schacht A; Helsberg K; Schreiber W; Schimmelmann BG; Lambert M
    J Psychiatr Res; 2008 Jul; 42(8):676-83. PubMed ID: 17720192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables.
    Naber D
    Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():133-8. PubMed ID: 8866775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subjective well-being in schizophrenia: a randomised controlled open-label 12-month non-inferiority study comparing quetiapine XR with risperidone (RECOVER).
    Naber D; Peuskens J; Schwarzmann N; Goltz M; Krüger H; Lambert M; Haro JM
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1257-69. PubMed ID: 23953270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs.
    Naber D; Moritz S; Lambert M; Pajonk FG; Holzbach R; Mass R; Andresen B
    Schizophr Res; 2001 May; 50(1-2):79-88. PubMed ID: 11378316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?
    Schennach-Wolff R; Jäger M; Obermeier M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Kühn KU; Lemke MR; Rüther E; Klingberg S; Gastpar M; Seemüller F; Möller HJ; Riedel M
    World J Biol Psychiatry; 2010 Aug; 11(5):729-38. PubMed ID: 20380620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential 3-year effects of first- versus second-generation antipsychotics on subjective well-being in schizophrenia using marginal structural models.
    Lambert M; Schimmelmann BG; Schacht A; Suarez D; Haro JM; Novick D; Wagner T; Wehmeier PM; Huber CG; Hundemer HP; Dittmann RW; Naber D
    J Clin Psychopharmacol; 2011 Apr; 31(2):226-30. PubMed ID: 21346606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subjective well-being, but not subjective mental functioning shows positive associations with neuropsychological performance in schizophrenia-spectrum disorders.
    Schroeder K; Huber CG; Jelinek L; Moritz S
    Compr Psychiatry; 2013 Oct; 54(7):824-30. PubMed ID: 23602393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refinement of the SWN-20 based on the Rasch rating model.
    Park IJ; Jung DC; Hwang SS; Jung HY; Yoon JS; Kim CE; Ahn YM; Kim YS
    Compr Psychiatry; 2015 Jul; 60():134-41. PubMed ID: 25819763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.